Reverberations for Ebos in Chemist Warehouse reverse listing

Reverberations for Ebos in Chemist Warehouse reverse listing
Sigma shareholders might well ask themselves if they're paying too much. (Image: NZME)
Paul McBeth
Discount pharmacist Chemist Warehouse’s reverse takeover of drugmaker Sigma Healthcare to build Australia’s biggest pharmacy group won’t immediately dent Ebos Group and may even offer some opportunities down the road. The discount pharmacist found its route onto the Australian securities exchange (ASX) via a reverse listing of Sigma, where Sigma will borrow A$1 billion (NZ$1.07b) from ANZ and National Australia Bank, give A$700m of that to the Chemist Warehouse shareholders and issue them shares equivalent to 85.8% of the...

More Markets

NZX 50 lifts 0.5% as Eroad continues to climb
Markets Market Close

NZX 50 lifts 0.5% as Eroad continues to climb

Metroglass shares were down after it announced its recapitalisation plan.

Metroglass recap plan hands control to Amari Metals
Markets

Metroglass recap plan hands control to Amari Metals

An independent report said Metroglass was left with “no viable alternatives”.

Vital presses remaining shareholders to back takeover
Markets

Vital presses remaining shareholders to back takeover

Vital wants shareholders to accept “without delay”.

The problem with wet sock small caps
Markets

Eden Bradfield: The problem with wet sock small caps

Why are smaller firms better off as private companies?

Eden Bradfield 09 Aug 2025